Zobrazeno 1 - 10
of 150
pro vyhledávání: '"Mark L, Weiss"'
Autor:
Carl P. Weiner, Helen Zhou, Howard Cuckle, Argyro Syngelaki, Kypros H. Nicolaides, Mark L. Weiss, Yafeng Dong
Publikováno v:
Biomedicines, Vol 11, Iss 4, p 1149 (2023)
The first-trimester prediction of spontaneous preterm birth (sPTB) has been elusive, and current screening is heavily dependent on obstetric history. However, nullipara lack a relevant history and are at higher risk for spontaneous (s)PTB ≤ 32 week
Externí odkaz:
https://doaj.org/article/2e22bfe00a0b445a8edc39f248b1a89e
Autor:
Carl P. Weiner, Mark L. Weiss, Helen Zhou, Argyro Syngelaki, Kypros H. Nicolaides, Yafeng Dong
Publikováno v:
Diagnostics, Vol 12, Iss 6, p 1410 (2022)
Prenatal trisomy 21 (T21) screening commonly involves testing a maternal blood sample for fetal DNA aneuploidy. It is reliable but poses a cost barrier to universal screening. We hypothesized maternal plasma RNA screening might provide similar reliab
Externí odkaz:
https://doaj.org/article/610f593f25e04ddda8060ce9af0987ad
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 9 (2021)
Following their discovery over 50 years ago, mesenchymal stromal cells (MSCs) have become one of the most studied cellular therapeutic products by both academia and industry due to their regenerative potential and immunomodulatory properties. The pro
Externí odkaz:
https://doaj.org/article/5d8e54680617438398f212a19296a33e
Autor:
Matthew L. Stone, Yunge Zhao, J. Robert Smith, Mark L. Weiss, Irving L. Kron, Victor E. Laubach, Ashish K. Sharma
Publikováno v:
Respiratory Research, Vol 18, Iss 1, Pp 1-12 (2017)
Abstract Background Lung ischemia-reperfusion (IR) injury after transplantation as well as acute shortage of suitable donor lungs are two critical issues impacting lung transplant patients. This study investigates the anti-inflammatory and immunomodu
Externí odkaz:
https://doaj.org/article/7f57727a2fc541609e977609827c2648
Publikováno v:
Pharmaceuticals, Vol 8, Iss 2, Pp 196-220 (2015)
Allogeneic hematopoietic cell transplantation (allo-HCT), a treatment option in hematologic malignancies and bone marrow failure syndromes, is frequently complicated by Graft-versus-host disease (GVHD). The primary treatment for GVHD involves immune
Externí odkaz:
https://doaj.org/article/0e248b1a3c4941e3894dd5a299842619
Publikováno v:
International Journal of Molecular Sciences; Volume 23; Issue 14; Pages: 7716
EVs can be isolated from a conditioned medium derived from mesenchymal stromal cells (MSCs), yet the effect of the pre-processing storage condition of the cell culture-conditioned medium prior to EV isolation is not well-understood. Since MSCs are al
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::628484e4319a0d6f405e32eaaa121999
Autor:
Adrienne Wright, Ying Yi Zheng, Amber Lee, Braden Ishler, Daniel A Sheik, Keith A Moskowitz, Mark L Weiss
Publikováno v:
Hematology & Transfusion International Journal. 9:41-51
Background: Cancer is a global health concern with millions of people diagnosed annually. Chemotherapy remains the primary treatment for many cancers despite its toxic side effects. Currently, there is focus on developing nanoparticle systems to enha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ff0e73e9babf31cbe2f4df75cb1c90ae
https://doi.org/10.15406/htij.2021.09.00251
https://doi.org/10.15406/htij.2021.09.00251
Autor:
Adrienne Wright, Orman (Larry) Snyder, Hong He, Lane K. Christenson, Sherry Fleming, Mark L. Weiss
Publikováno v:
International Journal of Molecular Sciences; Volume 24; Issue 11; Pages: 9216
Many cell types, including cancer cells, release tissue factor (TF)-exposing extracellular vesicles (EVs). It is unknown whether MSC-EVs pose a thromboembolism risk due to TF expression. Knowing that MSCs express TF and are procoagulant, we hypothesi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ac369ed95ce0d5e112407358eefa6fd
https://doi.org/10.3390/ijms24119216
https://doi.org/10.3390/ijms24119216
Publikováno v:
Stem Cells International, Vol 2016 (2016)
Externí odkaz:
https://doaj.org/article/eafc4dd932f44124b68de3f6eeb142a5
Publikováno v:
Stem Cells International, Vol 2016 (2016)
The great properties of human mesenchymal stromal cells (hMSCs) make these cells an important tool in regenerative medicine. Because of the limitations of hMSCs derived from the bone marrow during isolation and expansion, hMSCs derived from the umbil
Externí odkaz:
https://doaj.org/article/172c7a8ea5e34c9ca156fefed6efd0ca